Sex hormones have emerged as important modulators of cardiovascular physiology and pathophysiology. Our previous studies demonstrated that testosterone increases expression and activity of L-type, voltage-gated calcium channels (Ca v 1.2) in coronary arteries of males. The purpose of the present study was to determine whether testosterone (T) alters coronary protein kinase C ␦ (PKC␦) expression and whether PKC␦ plays a role in coronary Ca v 1.2 expression. For in vitro studies, porcine right coronary arteries (RCA) and post-confluent (passages 3-6) 5-day, serum-restricted coronary smooth muscle cell cultures (CSMC) were incubated in the presence and absence of T or dihydrotestosterone (10 and 100 nM) for 18 h at 37°C in a humidified chamber. For sex and endogenous testosterone-dependent effects, RCA were obtained from intact males, castrated males, castrated males with T replacement, and intact females. In vitro T and dihydrotestosterone caused an ϳ2-3-fold increase in PKC␦ protein levels, ϳ1.5-2-fold increase in PKC␦ kinase activity, and localization of PKC␦ toward the plasma membrane and nuclear envelope. PKC␦ protein levels were higher in coronary arteries of intact males compared with intact females. Elimination of endogenous testosterone by castration reduced RCA PKC␦ protein levels, an effect partially (ϳ45%) reversed by exogenous T (castrated males with T replacement). In CSMC, PKC inhibition with either the general PKC inhibitor, cheylerythrine, or the putative PKC␦ inhibitor, rottlerin, completely inhibited the T-mediated increase in coronary Ca v 1.2 protein levels. Conversely, Go6976, a conventional PKC isoform inhibitor, failed to inhibit T-induced increases in coronary Ca v 1.2 protein levels. PKC␦ short interference RNA completely blocked T-induced increases in Ca v 1.2 protein levels in CSMC. These results demonstrate for the first time that 1) endogenous T is a primary modulator of coronary PKC␦ protein and activity in males and 2) T increases Ca v 1.2 protein expression in a PKC␦-dependent manner.Coronary heart disease is a major cause of global mortality and represents an underlying cause for most heart attacks and sudden death (1). Men 30 -50 years of age have an increased incidence of coronary heart disease compared with women of similar age (2-4), a sex difference that led many to the conclusion that testosterone increases the risk of coronary heart disease in men. However, recent clinical studies have failed to support a detrimental effect of testosterone on coronary heart disease (5-7). On the contrary, low testosterone concentrations in men are associated with a higher risk of atherosclerosis (7). Men with low testosterone levels are often more obese, hypertensive, and have increased blood glucose and serum cholesterol levels and increased carotid artery atherosclerosis with diabetes (5, 7). Additionally, Dunajaska et al. (6) have shown that low levels of total testosterone, testosterone/estradiol ratio, and free androgen index are associated with coronary artery disease in men. These f...